ALEC
Price
$1.49
Change
+$0.08 (+5.67%)
Updated
Jun 6 closing price
Capitalization
148.99M
54 days until earnings call
EPRX
Price
$3.94
Change
-$0.00 (-0.00%)
Updated
Jun 6 closing price
Capitalization
139.14M
62 days until earnings call
Interact to see
Advertisement

ALEC vs EPRX

Header iconALEC vs EPRX Comparison
Open Charts ALEC vs EPRXBanner chart's image
Alector
Price$1.49
Change+$0.08 (+5.67%)
Volume$738.63K
Capitalization148.99M
Eupraxia Pharmaceuticals
Price$3.94
Change-$0.00 (-0.00%)
Volume$11K
Capitalization139.14M
ALEC vs EPRX Comparison Chart
Loading...
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALEC vs. EPRX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALEC is a StrongBuy and EPRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (ALEC: $1.49 vs. EPRX: $3.94)
Brand notoriety: ALEC and EPRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALEC: 75% vs. EPRX: 79%
Market capitalization -- ALEC: $148.99M vs. EPRX: $139.14M
ALEC [@Biotechnology] is valued at $148.99M. EPRX’s [@Biotechnology] market capitalization is $139.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALEC’s FA Score shows that 0 FA rating(s) are green whileEPRX’s FA Score has 0 green FA rating(s).

  • ALEC’s FA Score: 0 green, 5 red.
  • EPRX’s FA Score: 0 green, 5 red.
According to our system of comparison, EPRX is a better buy in the long-term than ALEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALEC’s TA Score shows that 5 TA indicator(s) are bullish while EPRX’s TA Score has 3 bullish TA indicator(s).

  • ALEC’s TA Score: 5 bullish, 3 bearish.
  • EPRX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ALEC is a better buy in the short-term than EPRX.

Price Growth

ALEC (@Biotechnology) experienced а +12.03% price change this week, while EPRX (@Biotechnology) price change was +1.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

ALEC is expected to report earnings on Jul 31, 2025.

EPRX is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALEC($149M) has a higher market cap than EPRX($139M). EPRX YTD gains are higher at: 24.290 vs. ALEC (-21.164). EPRX has higher annual earnings (EBITDA): -25.89M vs. ALEC (-137.59M). ALEC has more cash in the bank: 355M vs. EPRX (27.5M). EPRX has less debt than ALEC: EPRX (52.8K) vs ALEC (41M). ALEC has higher revenues than EPRX: ALEC (88.3M) vs EPRX (0).
ALECEPRXALEC / EPRX
Capitalization149M139M107%
EBITDA-137.59M-25.89M531%
Gain YTD-21.16424.290-87%
P/E RatioN/AN/A-
Revenue88.3M0-
Total Cash355M27.5M1,291%
Total Debt41M52.8K77,652%
FUNDAMENTALS RATINGS
ALEC: Fundamental Ratings
ALEC
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALECEPRX
RSI
ODDS (%)
N/A
Bearish Trend 5 days ago
69%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
68%
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
40%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
57%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 5 days ago
86%
Declines
ODDS (%)
Bearish Trend 25 days ago
88%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
70%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WILCX10.260.05
+0.49%
Wasatch Global Value Institutional
ASVDX9.55N/A
N/A
American Century Small Cap Value R6
GMOWX17.24N/A
N/A
GMO Resources VI
MSBQX12.00N/A
N/A
Morgan Stanley American Resilience R6
IVIPX41.17N/A
N/A
VY® Invesco Equity and Income S2

ALEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALEC has been loosely correlated with ABOS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ALEC jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALEC
1D Price
Change %
ALEC100%
+5.67%
ABOS - ALEC
49%
Loosely correlated
+12.15%
RGNX - ALEC
49%
Loosely correlated
+14.95%
BEAM - ALEC
49%
Loosely correlated
+9.26%
DNLI - ALEC
47%
Loosely correlated
+3.38%
EYPT - ALEC
47%
Loosely correlated
+8.36%
More

EPRX and

Correlation & Price change

A.I.dvisor tells us that EPRX and CCCC have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EPRX and CCCC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPRX
1D Price
Change %
EPRX100%
N/A
CCCC - EPRX
29%
Poorly correlated
+17.69%
ETNB - EPRX
28%
Poorly correlated
+2.91%
ACAD - EPRX
28%
Poorly correlated
+3.00%
FDMT - EPRX
26%
Poorly correlated
+11.25%
ALEC - EPRX
26%
Poorly correlated
+5.67%
More